Canada - English - Health Canada

valeant groupe cosmederme inc - octinoxate; oxybenzone; zinc oxide; titanium dioxide - cream - 7.5%; 3%; 6%; 5% - octinoxate 7.5%; oxybenzone 3%; zinc oxide 6%; titanium dioxide 5% - sunscreen agents

Canada - English - Health Canada

valeant groupe cosmederme inc - octocrylene; octinoxate; titanium dioxide; avobenzone; zinc oxide - cream - 10%; 7.5%; 3.75%; 3%; 0.435% - octocrylene 10%; octinoxate 7.5%; titanium dioxide 3.75%; avobenzone 3%; zinc oxide 0.435% - sunscreen agents

Canada - English - Health Canada

valeant groupe cosmederme inc - octisalate; oxybenzone; octinoxate - stick - 3%; 3%; 7.5% - octisalate 3%; oxybenzone 3%; octinoxate 7.5% - sunscreen agents

Canada - English - Health Canada

valeant groupe cosmederme inc - octinoxate; avobenzone - cream - 7.9%; 3% - octinoxate 7.9%; avobenzone 3% - sunscreen agents

Canada - English - Health Canada

valeant groupe cosmederme inc - titanium dioxide; octinoxate - cream - 2%; 7.75% - titanium dioxide 2%; octinoxate 7.75% - sunscreen agents

Canada - English - Health Canada

valeant groupe cosmederme inc - homosalate; oxybenzone; octisalate; octocrylene; avobenzone - cream - 7.5%; 5.5%; 5.0%; 3.75%; 3.0% - homosalate 7.5%; oxybenzone 5.5%; octisalate 5.0%; octocrylene 3.75%; avobenzone 3.0% - sunscreen agents

Canada - English - Health Canada

valeant groupe cosmederme inc - benzoyl peroxide - kit - 5% - benzoyl peroxide 5% - keratolytic agents

Canada - English - Health Canada

valeant groupe cosmederme inc - octocrylene; avobenzone; octinoxate; titanium dioxide - cream - 3%; 3%; 1.05%; 0.75% - octocrylene 3%; avobenzone 3%; octinoxate 1.05%; titanium dioxide 0.75% - sunscreen agents

United States - English - NLM (National Library of Medicine)

bausch health us, llc - secobarbital sodium (unii: xbp604f6um) (secobarbital - unii:1p7h87in75) - secobarbital sodium 100 mg - seconal sodium is contraindicated in patients who are hypersensitive to barbiturates. it is also contraindicated in patients with a history of manifest or latent porphyria, marked impairment of liver function, or respiratory disease in which dyspnea or obstruction is evident. abuse and addiction are separate and distinct from physical dependence and tolerance. abuse is characterized by misuse of the drug for non-medical purposes, often in combination with other psychoactive substances. physical dependence is a state of adaptation that is manifested by a specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug and/or administration of an antagonist. tolerance is a state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug's effects over time. tolerance may occur to both the desired and undesired effects of drugs and may develop at different rates for different effects. addiction is

Singapore - English - HSA (Health Sciences Authority)

bausch & lomb (singapore) private limited - ophthalmology - eyefill c. is a medical device intended for intraocular use during ophthalmic anterior and posterior segment surgery. it protects the intraocular tissue and prevents adhesions and synechia formation during the procedure.